Sustained release of antibiotic from polyurethane coated implant materials.
Implant associated infections are of increasing importance. To minimize the risks of implant-associated infections recent biomedical strategies have led to the modification of the medical device surfaces. The modifications are in the terms of increasing surface biocompatibility and decreasing bacterial adherence, which can be achieved by applying a coating of biocompatible polymer onto the said surfaces. Entrapping anti-infective agents in a polymer matrix provides an approach to kill bacteria and combat the possibility of any residual infection. We have prepared a biodegradable polyester urethane coat for implant materials, which have the property to accommodate antibiotics within itself. These polyurethane coating materials were characterized by FTIR spectroscopy, swelling property in SBF, gravimetric analysis, drug release, and biocompatibility study. Drug release rates, bacterial colonization and morphological features were also evaluated to predict and understand the antimicrobial activity of these delivery systems. Drug release characteristics were investigated and the physico-chemical mechanisms of the delivery were discussed. Results suggest that the polyester urethane can be used as an implant coating material and can be used as a matrix for the sustained delivery of anti-infective agent.
Basak
Piyali
P
Materials Science Centre, Indian Institute of Technology, Kharagpur 721302, India.
Adhikari
Basudam
B
Banerjee
Indranil
I
Maiti
Tapas K
TK
D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000493:pharmacokinetics*; D018441:Biofilms / Q000187:drug effects; D001826:Body Fluids / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D020099:Coated Materials, Biocompatible / Q000138:chemical synthesis / Q000737:chemistry* / Q000493:pharmacokinetics*; D003692:Delayed-Action Preparations / Q000493:pharmacokinetics; D006801:Humans; D006868:Hydrolysis; D008826:Microbial Sensitivity Tests; D008954:Models, Biological; D011140:Polyurethanes / Q000138:chemical synthesis / Q000737:chemistry*; D019736:Prostheses and Implants; D012293:Rifampin / Q000378:metabolism / Q000493:pharmacokinetics; D012867:Skin / Q000166:cytology / Q000187:drug effects; D017550:Spectroscopy, Fourier Transform Infrared; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible; D003692:Delayed-Action Preparations; D011140:Polyurethanes; D012293:Rifampin